Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03ABH
|
|||
| Former ID |
DIB006118
|
|||
| Drug Name |
Deriglidole
|
|||
| Synonyms |
SL-84.0418; SL-84.0714; SL-84.0715
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Discontinued in Phase 2 | [1] | |
| Company |
Synthelabo
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H21N3
|
|||
| Canonical SMILES |
CCCC1(CC2=CC=CC3=C2N1CC3)C4=NCCN4
|
|||
| InChI |
1S/C16H21N3/c1-2-7-16(15-17-8-9-18-15)11-13-5-3-4-12-6-10-19(16)14(12)13/h3-5H,2,6-11H2,1H3,(H,17,18)
|
|||
| InChIKey |
BADQRNHAZHSOKC-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 122830-14-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000010) | |||
| REF 2 | Mechanisms of the hypoglycemic effects of the alpha2-adrenoceptor antagonists SL84.0418 and deriglidole. Life Sci. 1998;62(9):839-52. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.